Economics at your fingertips  

Impact of the excise tax on firm R&D and performance in the medical device industry: Evidence from the Affordable Care Act

Daeyong Lee

Research Policy, 2018, vol. 47, issue 5, 854-871

Abstract: This article examines how the excise tax affects firms’ R&D investment, performance, and market strategy in the US medical device industry. The Affordable Care Act imposed a 2.3% excise tax on medical devices beginning in January 2013, and thus this study compares the medical device firms with other high-tech firms before and after the tax incidence. Using COMPUSTAT data from 2006 to 2015, the author finds that the excise tax reduced R&D investment, sales revenue, gross margins, and earnings for medical device firms. In addition, the excise tax increased their global market sales intensity, global market diversification, and customer diversification in the US domestic market.

Keywords: Medical device tax; Research and development (R&D); Firm performance; Market strategy; Affordable Care Act (search for similar items in EconPapers)
JEL-codes: H25 O32 L25 I11 G38 (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations Track citations by RSS feed

Downloads: (external link)
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this article

Research Policy is currently edited by M. Bell, B. Martin, W.E. Steinmueller, A. Arora, M. Callon, M. Kenney, S. Kuhlmann, Keun Lee and F. Murray

More articles in Research Policy from Elsevier
Bibliographic data for series maintained by Dana Niculescu ().

Page updated 2018-06-07
Handle: RePEc:eee:respol:v:47:y:2018:i:5:p:854-871